SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,909.70 -570.59
( -0.79%)

Global Indices

Nasdaq

50,945.10 -425.82
(-0.83%)

Dow Jones

7,674.56 -17.28
(-0.22%)

Hang Seng

68,949.71 2,195.99
(3.29%)

Nikkei 225

10,610.72 -25.99
(-0.24%)

Forex

USD-INR

95.97 0.01
(0.01%)

EUR-INR

108.89 -0.26
(-0.24%)

GBP-INR

126.98 -0.19
(-0.15%)

JPY-INR

0.61 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524715

INE044A01036

93.2373503

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SUNPHARMA

137.15

436678.96

EPS(TTM)

Face Value()

Div & Yield %

13.27

0.88

Back

srs ltd

Jagsonpal Pharmaceuticals standalone net profit rises 22.13% in the June 2026 quarter

Jul 29,2026

Net profit of Jagsonpal Pharmaceuticals rose 22.13% to Rs 13.19 crore in the quarter ended June 2026 as against Rs 10.80 crore during the previous quarter ended June 2025. Sales rose 8.76% to Rs 82.23 crore in the quarter ended June 2026 as against Rs 75.61 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	82.23	75.61	9
OPM %	20.97	18.79	-
PBDT	19.82	16.79	18
PBT	17.68	14.44	22
NP	13.19	10.80	22

71,909.70 -570.59 ( -0.79%)

50,945.10 -425.82 (-0.83%)

7,674.56 -17.28 (-0.22%)

68,949.71 2,195.99 (3.29%)

10,610.72 -25.99 (-0.24%)

95.97 0.01 (0.01%)

108.89 -0.26 (-0.24%)

126.98 -0.19 (-0.15%)

0.61 0.00 (0.01%)